Clinical Trial Update: A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of bortezomib, cyclophosphamide, and dexamethasone in untreated multiple myeloma patients planned for high-dose chemoth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (Velcade) (Bortezomib)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Dexamethasone (Decadron) (dexamethasone)

Snippet

Sponsor: Janssen-Cilag G.m.b.H | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2014-03-03